PharVision Advisers’s Playtika PLTK Stock Holding History

PharVision Advisers’s Portfolio PLTK Stock Details PLTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-85,073	Closed	-$331K	–	934
2025 Q3	$331K	Buy	+85,073	New	+$347K	0.19%	171

Other funds holding PLTK

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's PLTK Position: Q4 2025 in Review

PharVision Advisers sold out of Playtika (PLTK) in Q4 2025, closing a stake of 85,073 shares — an estimated $331K sold.

PharVision Advisers first reported a position in PLTK in Q3 2025 and held it in 1 quarter. The position peaked at $331K in Q3 2025. 186 funds tracked by Wall St. Rank hold PLTK as of Q4 2025.

PharVision Advisers reported no remaining Playtika position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 85,073 Playtika shares in Q4 2025, an estimated $331K.
PharVision Advisers first reported a position in Playtika in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Playtika position peaked at $331K in Q3 2025.
186 funds tracked by Wall St. Rank held Playtika as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.